Chempartner Pharmatech Co Ltd Class A 300149
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 4.35
- Day Range
- CNY 4.28–4.44
- 52-Week Range
- CNY 3.68–9.74
- Bid/Ask
- CNY 4.40 / CNY 4.41
- Market Cap
- CNY 2.20 Bil
- Volume/Avg
- 4.9 Mil / 9.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.97
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Chempartner Pharmatech Co Ltd is engaged in the research, development, production, and operation of prebiotics, micro-ecological medical, and biopharmaceuticals.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,916
- Website
- https://www.cppt.com.cn
Comparables
Valuation
|
Metric
|
300149
|
301207
|
000403
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 15.14 | 32.92 |
Price/Book Value | 1.51 | 1.74 | 2.80 |
Price/Sales | 1.97 | 4.79 | 8.40 |
Price/Cash Flow | 11.04 | 13.92 | 40.41 |
Price/Earnings
300149
301207
000403
Financial Strength
|
Metric
|
300149
|
301207
|
000403
|
|---|---|---|---|
Quick Ratio | 1.54 | 3.16 | 2.66 |
Current Ratio | 1.76 | 3.65 | 4.01 |
Interest Coverage | −30.81 | 154.28 | 88.68 |
Quick Ratio
300149
301207
000403
Profitability
|
Metric
|
300149
|
301207
|
000403
|
|---|---|---|---|
Return on Assets (Normalized) | −29.89% | 9.39% | 7.64% |
Return on Equity (Normalized) | −45.72% | 11.86% | 8.84% |
Return on Invested Capital (Normalized) | −33.66% | 11.24% | 7.59% |
Return on Assets
300149
301207
000403
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Hprjbjjpy | Shk | $626.5 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Nryqkxh | Wywhkk | $122.2 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Vvfslhx | Xbbcc | $115.2 Bil | |||
| Moderna Inc
MRNA
| Kcyrgnyq | Vccg | $52.8 Bil | |||
| argenx SE ADR
ARGX
| Prcdlpc | Fpwjf | $22.6 Bil | |||
| BioNTech SE ADR
BNTX
| Kzbkbnl | Bcnq | $21.3 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Hjdcpdkj | Rmhdss | $19.9 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Qwkwyxv | Ddpysg | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Vcdhlmzbc | Xsng | $13.2 Bil | |||
| Incyte Corp
INCY
| Nzjvjrjfv | Ghmsrk | $12.4 Bil |